6.13
-0.65
(-9.59%)
As of April 3 at 4:00:01 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.57 | -0.37 | -2.19 | -2.7 |
| Low Estimate | -0.61 | -0.63 | -2.74 | -3.2 |
| High Estimate | -0.51 | 0.45 | -1.28 | -2.45 |
| Year Ago EPS | -3.55 | -0.39 | -2.18 | -2.19 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | 7.5M | 7.5M | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | 30M | 30M | -- |
| Year Ago Sales | -- | -- | -- | 7.5M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -100.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.33 | -0.35 | -0.43 | -0.44 |
| EPS Actual | -3.55 | -0.39 | -0.4 | -0.56 |
| Difference | -2.22 | -0.04 | 0.02 | -0.13 |
| Surprise % | -166.25% | -12.50% | 5.88% | -28.74% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.57 | -0.37 | -2.19 | -2.7 |
| 7 Days Ago | -0.55 | -0.36 | -2.16 | -2.69 |
| 30 Days Ago | 0 | 0 | -1.62 | -2.84 |
| 60 Days Ago | 0 | 0 | -1.62 | -2.84 |
| 90 Days Ago | 0 | 0 | -1.62 | -2.84 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 3 | 2 |
| Down Last 30 Days | -- | -- | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CTNM | 83.94% | 5.64% | -0.55% | -23.18% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | Jones Trading: Buy | 3/13/2025 |
| Maintains | Baird: Outperform to Outperform | 3/7/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/9/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 11/7/2024 |
| Initiated | Baird: Outperform | 10/22/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 8/14/2024 |
Related Tickers
BOLD Boundless Bio, Inc.
1.3400
-2.90%
ARTV Artiva Biotherapeutics, Inc.
2.4200
-4.72%
RAPP Rapport Therapeutics, Inc.
7.90
-7.28%
MBX MBX Biosciences, Inc.
6.34
-0.47%
CAMP CAMP4 THERAPEUTICS CORPORATION
3.0900
-12.34%
AARD Aardvark Therapeutics, Inc.
8.23
-5.29%
MOLN Molecular Partners AG
3.7201
-3.37%
MAZE Maze Therapeutics, Inc.
9.32
-10.13%
TSBX Turnstone Biologics Corp.
0.3770
-0.74%
SYRE Spyre Therapeutics, Inc.
13.43
-4.00%